Global Generic Injectables Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Small Molecule
1.2.3 Large Molecule
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Injectables Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Generic Injectables Revenue Market Share by Region (2020-2025)
2.4 Global Generic Injectables Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Generic Injectables Market Size and Prospective (2020-2031)
2.5.2 Europe Generic Injectables Market Size and Prospective (2020-2031)
2.5.3 China Generic Injectables Market Size and Prospective (2020-2031)
2.5.4 Japan Generic Injectables Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Generic Injectables Historic Market Size by Type (2020-2025)
3.2 Global Generic Injectables Forecasted Market Size by Type (2026-2031)
3.3 Different Types Generic Injectables Representative Players
4 Breakdown Data by Application
4.1 Global Generic Injectables Historic Market Size by Application (2020-2025)
4.2 Global Generic Injectables Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Generic Injectables Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Generic Injectables Players by Revenue (2020-2025)
5.1.2 Global Generic Injectables Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Generic Injectables Revenue
5.4 Global Generic Injectables Market Concentration Analysis
5.4.1 Global Generic Injectables Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Generic Injectables Revenue in 2024
5.5 Global Key Players of Generic Injectables Head office and Area Served
5.6 Global Key Players of Generic Injectables, Product and Application
5.7 Global Key Players of Generic Injectables, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Generic Injectables Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Generic Injectables Market Size by Type (2020-2025)
6.1.2.2 North America Generic Injectables Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Generic Injectables Market Size by Application (2020-2025)
6.1.3.2 North America Generic Injectables Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Generic Injectables Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Generic Injectables Market Size by Type (2020-2025)
6.2.2.2 Europe Generic Injectables Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Generic Injectables Market Size by Application (2020-2025)
6.2.3.2 Europe Generic Injectables Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Generic Injectables Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Generic Injectables Market Size by Type (2020-2025)
6.3.2.2 China Generic Injectables Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Generic Injectables Market Size by Application (2020-2025)
6.3.3.2 China Generic Injectables Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Generic Injectables Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Generic Injectables Market Size by Type (2020-2025)
6.4.2.2 Japan Generic Injectables Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Generic Injectables Market Size by Application (2020-2025)
6.4.3.2 Japan Generic Injectables Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Hospira (Pfizer Inc.)
7.1.1 Hospira (Pfizer Inc.) Company Details
7.1.2 Hospira (Pfizer Inc.) Business Overview
7.1.3 Hospira (Pfizer Inc.) Generic Injectables Introduction
7.1.4 Hospira (Pfizer Inc.) Revenue in Generic Injectables Business (2020-2025)
7.1.5 Hospira (Pfizer Inc.) Recent Development
7.2 Fresenius Kabi
7.2.1 Fresenius Kabi Company Details
7.2.2 Fresenius Kabi Business Overview
7.2.3 Fresenius Kabi Generic Injectables Introduction
7.2.4 Fresenius Kabi Revenue in Generic Injectables Business (2020-2025)
7.2.5 Fresenius Kabi Recent Development
7.3 Sandoz (Novartis)
7.3.1 Sandoz (Novartis) Company Details
7.3.2 Sandoz (Novartis) Business Overview
7.3.3 Sandoz (Novartis) Generic Injectables Introduction
7.3.4 Sandoz (Novartis) Revenue in Generic Injectables Business (2020-2025)
7.3.5 Sandoz (Novartis) Recent Development
7.4 Hikma Pharmaceuticals PLC
7.4.1 Hikma Pharmaceuticals PLC Company Details
7.4.2 Hikma Pharmaceuticals PLC Business Overview
7.4.3 Hikma Pharmaceuticals PLC Generic Injectables Introduction
7.4.4 Hikma Pharmaceuticals PLC Revenue in Generic Injectables Business (2020-2025)
7.4.5 Hikma Pharmaceuticals PLC Recent Development
7.5 Dr. Reddy’s Laboratories Ltd
7.5.1 Dr. Reddy’s Laboratories Ltd Company Details
7.5.2 Dr. Reddy’s Laboratories Ltd Business Overview
7.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectables Introduction
7.5.4 Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectables Business (2020-2025)
7.5.5 Dr. Reddy’s Laboratories Ltd Recent Development
7.6 Grifols
7.6.1 Grifols Company Details
7.6.2 Grifols Business Overview
7.6.3 Grifols Generic Injectables Introduction
7.6.4 Grifols Revenue in Generic Injectables Business (2020-2025)
7.6.5 Grifols Recent Development
7.7 Nichi-Iko Group (Sagent)
7.7.1 Nichi-Iko Group (Sagent) Company Details
7.7.2 Nichi-Iko Group (Sagent) Business Overview
7.7.3 Nichi-Iko Group (Sagent) Generic Injectables Introduction
7.7.4 Nichi-Iko Group (Sagent) Revenue in Generic Injectables Business (2020-2025)
7.7.5 Nichi-Iko Group (Sagent) Recent Development
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Company Details
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Generic Injectables Introduction
7.8.4 Teva Pharmaceutical Revenue in Generic Injectables Business (2020-2025)
7.8.5 Teva Pharmaceutical Recent Development
7.9 Auromedics
7.9.1 Auromedics Company Details
7.9.2 Auromedics Business Overview
7.9.3 Auromedics Generic Injectables Introduction
7.9.4 Auromedics Revenue in Generic Injectables Business (2020-2025)
7.9.5 Auromedics Recent Development
7.10 Sanofi
7.10.1 Sanofi Company Details
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Generic Injectables Introduction
7.10.4 Sanofi Revenue in Generic Injectables Business (2020-2025)
7.10.5 Sanofi Recent Development
7.11 Gland Pharma
7.11.1 Gland Pharma Company Details
7.11.2 Gland Pharma Business Overview
7.11.3 Gland Pharma Generic Injectables Introduction
7.11.4 Gland Pharma Revenue in Generic Injectables Business (2020-2025)
7.11.5 Gland Pharma Recent Development
7.12 Endo International PLC
7.12.1 Endo International PLC Company Details
7.12.2 Endo International PLC Business Overview
7.12.3 Endo International PLC Generic Injectables Introduction
7.12.4 Endo International PLC Revenue in Generic Injectables Business (2020-2025)
7.12.5 Endo International PLC Recent Development
8 Generic Injectables Market Dynamics
8.1 Generic Injectables Industry Trends
8.2 Generic Injectables Market Drivers
8.3 Generic Injectables Market Challenges
8.4 Generic Injectables Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Global Generic Injectables Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Generic Injectables Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Generic Injectables Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Generic Injectables Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Generic Injectables Revenue Share by Region (2020-2025)
Table 6. Global Generic Injectables Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Generic Injectables Revenue Share Forecast by Region (2026-2031)
Table 8. Global Generic Injectables Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Generic Injectables Revenue Market Share by Type (2020-2025)
Table 10. Global Generic Injectables Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Generic Injectables Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Generic Injectables Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Generic Injectables Revenue Market Share by Application (2020-2025)
Table 15. Global Generic Injectables Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Generic Injectables Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Generic Injectables Application
Table 18. Global Generic Injectables Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Generic Injectables Market Share by Players (2020-2025)
Table 20. Global Top Generic Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectables as of 2024)
Table 21. Ranking of Global Top Generic Injectables Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Generic Injectables Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Generic Injectables, Headquarters and Area Served
Table 24. Global Key Players of Generic Injectables, Product and Application
Table 25. Global Key Players of Generic Injectables, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Generic Injectables Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Generic Injectables Revenue Market Share by Company (2020-2025)
Table 29. North America Generic Injectables Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Generic Injectables Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Generic Injectables Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Generic Injectables Revenue Market Share by Company (2020-2025)
Table 33. Europe Generic Injectables Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Generic Injectables Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Generic Injectables Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Generic Injectables Revenue Market Share by Company (2020-2025)
Table 37. China Generic Injectables Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Generic Injectables Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Generic Injectables Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Generic Injectables Revenue Market Share by Company (2020-2025)
Table 41. Japan Generic Injectables Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Generic Injectables Market Size by Application (2020-2025) & (US$ Million)
Table 43. Hospira (Pfizer Inc.) Company Details
Table 44. Hospira (Pfizer Inc.) Business Overview
Table 45. Hospira (Pfizer Inc.) Generic Injectables Product
Table 46. Hospira (Pfizer Inc.) Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 47. Hospira (Pfizer Inc.) Recent Development
Table 48. Fresenius Kabi Company Details
Table 49. Fresenius Kabi Business Overview
Table 50. Fresenius Kabi Generic Injectables Product
Table 51. Fresenius Kabi Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 52. Fresenius Kabi Recent Development
Table 53. Sandoz (Novartis) Company Details
Table 54. Sandoz (Novartis) Business Overview
Table 55. Sandoz (Novartis) Generic Injectables Product
Table 56. Sandoz (Novartis) Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 57. Sandoz (Novartis) Recent Development
Table 58. Hikma Pharmaceuticals PLC Company Details
Table 59. Hikma Pharmaceuticals PLC Business Overview
Table 60. Hikma Pharmaceuticals PLC Generic Injectables Product
Table 61. Hikma Pharmaceuticals PLC Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 62. Hikma Pharmaceuticals PLC Recent Development
Table 63. Dr. Reddy’s Laboratories Ltd Company Details
Table 64. Dr. Reddy’s Laboratories Ltd Business Overview
Table 65. Dr. Reddy’s Laboratories Ltd Generic Injectables Product
Table 66. Dr. Reddy’s Laboratories Ltd Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 67. Dr. Reddy’s Laboratories Ltd Recent Development
Table 68. Grifols Company Details
Table 69. Grifols Business Overview
Table 70. Grifols Generic Injectables Product
Table 71. Grifols Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 72. Grifols Recent Development
Table 73. Nichi-Iko Group (Sagent) Company Details
Table 74. Nichi-Iko Group (Sagent) Business Overview
Table 75. Nichi-Iko Group (Sagent) Generic Injectables Product
Table 76. Nichi-Iko Group (Sagent) Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 77. Nichi-Iko Group (Sagent) Recent Development
Table 78. Teva Pharmaceutical Company Details
Table 79. Teva Pharmaceutical Business Overview
Table 80. Teva Pharmaceutical Generic Injectables Product
Table 81. Teva Pharmaceutical Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 82. Teva Pharmaceutical Recent Development
Table 83. Auromedics Company Details
Table 84. Auromedics Business Overview
Table 85. Auromedics Generic Injectables Product
Table 86. Auromedics Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 87. Auromedics Recent Development
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Generic Injectables Product
Table 91. Sanofi Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. Gland Pharma Company Details
Table 94. Gland Pharma Business Overview
Table 95. Gland Pharma Generic Injectables Product
Table 96. Gland Pharma Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 97. Gland Pharma Recent Development
Table 98. Endo International PLC Company Details
Table 99. Endo International PLC Business Overview
Table 100. Endo International PLC Generic Injectables Product
Table 101. Endo International PLC Revenue in Generic Injectables Business (2020-2025) & (US$ Million)
Table 102. Endo International PLC Recent Development
Table 103. Generic Injectables Market Trends
Table 104. Generic Injectables Market Drivers
Table 105. Generic Injectables Market Challenges
Table 106. Generic Injectables Market Restraints
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources


List of Figures
Figure 1. Generic Injectables Product Picture
Figure 2. Global Generic Injectables Market Share by Type: 2024 VS 2031
Figure 3. Small Molecule Features
Figure 4. Large Molecule Features
Figure 5. Global Generic Injectables Market Share by Application: 2024 VS 2031
Figure 6. Oncology
Figure 7. Anesthesia
Figure 8. Anti-Infectives
Figure 9. Parenteral Nutrition
Figure 10. Cardiovascular Diseases
Figure 11. Generic Injectables Report Years Considered
Figure 12. Global Generic Injectables Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Generic Injectables Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Generic Injectables Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Generic Injectables Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Generic Injectables Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Generic Injectables Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Generic Injectables Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Generic Injectables Market Share by Players in 2024
Figure 20. Global Top Generic Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectables as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Generic Injectables Revenue in 2024
Figure 22. North America Generic Injectables Market Share by Type (2020-2025)
Figure 23. North America Generic Injectables Market Share by Application (2020-2025)
Figure 24. Europe Generic Injectables Market Share by Type (2020-2025)
Figure 25. Europe Generic Injectables Market Share by Application (2020-2025)
Figure 26. China Generic Injectables Market Share by Type (2020-2025)
Figure 27. China Generic Injectables Market Share by Application (2020-2025)
Figure 28. Japan Generic Injectables Market Share by Type (2020-2025)
Figure 29. Japan Generic Injectables Market Share by Application (2020-2025)
Figure 30. Hospira (Pfizer Inc.) Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 31. Fresenius Kabi Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 32. Sandoz (Novartis) Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 33. Hikma Pharmaceuticals PLC Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 34. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 35. Grifols Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 36. Nichi-Iko Group (Sagent) Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 37. Teva Pharmaceutical Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 38. Auromedics Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 39. Sanofi Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 40. Gland Pharma Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 41. Endo International PLC Revenue Growth Rate in Generic Injectables Business (2020-2025)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit